https://www.zacks.com/stock/news/2229444/sight-sciences-sght-to-expand-in-europe-with-new-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2229444
Feb 21, 2024 - By tapping into the European market, Sight Sciences (SGHT) aims to capitalize on the growing demand for advanced eye care technologies.
zc:-3867282137457613631
0
https://www.zacks.com/stock/news/2232656/here-s-why-investors-should-retain-steris-ste-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2232656
Feb 27, 2024 - Investors are optimistic about STERIS (STE) on continuous recovery of healthcare procedures and upbeat 2024 guidance.
zc:-6136510649045583319
0
https://www.zacks.com/stock/news/2232605/hae-or-syk-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2232605
Feb 27, 2024 - HAE vs. SYK: Which Stock Is the Better Value Option?
zc:1212885221901401874
0
https://www.zacks.com/stock/news/2236218/cvs-health-cvs-expands-in-home-diagnostic-care-with-new-test?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2236218
Mar 05, 2024 - CVS Health's (CVS) new launch will enable early detection of heart arrhythmia and can help mitigate symptoms and more severe complications.
zc:1065628131519793942
0
https://www.zacks.com/stock/news/2236222/reasons-to-retain-prestige-consumer-pbh-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2236222
Mar 05, 2024 - Investors are optimistic about Prestige Consumer (PBH) on increasing gain in market share for its wide array of brands.
zc:8602494584614886584
0
https://www.zacks.com/stock/news/2237550/abbott-abt-to-reduce-childhood-malnutrition-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2237550
Mar 07, 2024 - Abbott's (ABT) latest partnership supports its sustainability goal of transforming care for malnutrition and improving the lives of 3 billion people per year by the decade's end.
zc:1815782283625796570
0
https://www.zacks.com/stock/news/2237551/here-s-why-you-should-retain-walgreens-boots-wba-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237551
Mar 07, 2024 - Investors are optimistic about Walgreens Boots (WBA), led by its strategic partnerships and long-term growth model.
zc:-4688381384700326572
0
https://www.zacks.com/stock/news/2238698/medtronic-s-mdt-minimed-780g-system-study-data-favorable?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238698
Mar 11, 2024 - Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.
zc:7753606710316964133
0
https://www.zacks.com/stock/news/2239482/integra-lifesciences-iart-introduces-micromatrix-flex?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2239482
Mar 12, 2024 - Integra LifeSciences' (IART) MicroMatrix Flex has a flexible tip that delivers a flowable version of the Urinary Bladder Matrix (UBM) technology.
zc:2889636430470051462
0
https://www.zacks.com/stock/news/2240217/here-s-why-you-should-retain-globus-medical-gmed-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2240217
Mar 13, 2024 - Investors are optimistic about Globus Medical (GMED), led by growth in the U.S. spine business and progress in the recently merged NuVasive business.
zc:7764675028236831377
0